NCT05546047View on ClinicalTrials.gov

A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients

PHASE4UnknownINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 14, 2019

Primary Completion Date

October 27, 2023

Study Completion Date

October 27, 2024

Conditions
Fibrillary Glomerulonephritis
Interventions
DRUG

Acthar Gel 80 UNT/ML Injectable Solution

Follow up and observation for 12 months off Acthar gel or Acthar gel and Tacrolimus

Trial Locations (5)

10032

Columbia University Research Dept of Nephrology, New York

18017

Northeast Clinical Research Center, Bethlehem

30046

Georgia Nephrology DBA Georgia Nephrology Research Institute, Lawrenceville

80045

University of Colorado Anschutz Medical Department of Medicine Division of Renal Diseases and Hypertension, Aurora

94305

Stanford University, Stanford

Sponsors

Collaborators (1)

Mallinckrodt
All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

NephroNet, Inc.

OTHER